# Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children

> **NCT03682211** · PHASE4 · COMPLETED · sponsor: **University College Dublin** · enrollment: 31 (actual)

## Conditions studied

- Pain
- Sickle Cell Disease

## Interventions

- **DRUG:** Fentanyl Citrate
- **DRUG:** Morphine sulphate

## Key facts

- **NCT ID:** NCT03682211
- **Lead sponsor:** University College Dublin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-12
- **Primary completion:** 2013-11-14
- **Final completion:** 2013-11-14
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-09-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03682211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03682211, "Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03682211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*